ProCE Banner Activity

Rapid Decrease in Pruritus With Ruxolitinib Cream for Patients With Atopic Dermatitis: Pooled Results From TRuE-AD1 and TRuE-AD2

Slideset Download
Conference Coverage
Rapid, clinically meaningful, and continual improvement in itch observed with ruxolitinib cream for patients with atopic dermatitis.

Released: June 18, 2021

Expiration: June 17, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Incyte Corporation